MultiplexDX

MultiplexDX

Private
BratislavaHealthcare & Life Scienceshttps://www.multiplexdx.com/

Last Round

Grant

Mar 7, 2025

Total Funding Raised

$4.82M

Company Overview

MultiplexDX is a biotechnology company that manufactures diagnostics kits and provides services intended to eliminate cancer misdiagnosis. The company's services combine molecular biology and histopathological methods for the treatment of tumors and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

molecular diagnosticscancer diagnosticsbreast cancer diagnosticsRNA sequencingRNA-seqRNA FISHspatial biologyprecision oncologycompanion diagnosticsprognostic testgene expression analysisbioinformatics servicesin vitro diagnosticsIVDcustom oligonucleotidesRT-qPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MultiplexDX Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MultiplexDX Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMar 7, 2025
VC RoundJun 27, 2023
GrantDec 12, 2019
SeedSep 1, 2018
GrantJul 1, 2018
Seed
May 16, 2016

Key People

Founding team and executive leadership

Pavol Cekan

Founder CEO

Founding Team

Petra Lipnicka

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2025

    Grew 15% QoQ, from 39 to 45 employees.

  • Mar 7, 2025

    Secured $6.3M in grant funding.

MultiplexDX Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MultiplexDX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MultiplexDX's valuation, stock price, and market status.

Firmographic Details

HeadquartersBratislava
Employee Range43
Year Founded2015
Last FundingMar 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.